Estrogen and progesterone treatment mimicking pregnancy for protection from breast cancer

In Vivo

Volumn 22, Issue 2, 2008, Pages 191-202

  Tsubura, Airo ^a   Uehara, Norihisa ^a   Matsuoka, Yoichiro ^a   Yoshizawa, Katsuhiko ^a   Yuri, Takashi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Estrogen; Mammary cancer; Pregnancy; Progesterone; Review; Rodent models

Indexed keywords

ESTRADIOL; PROGESTERONE;

AGE DISTRIBUTION; BREAST CANCER; BREAST CELL; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; EPITHELIUM CELL; ESTRADIOL BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LACTATION; LONG TERM CARE; NONHUMAN; PREGNANCY; PROGESTERONE BLOOD LEVEL; REVIEW; TREATMENT DURATION;

EID: 42149146212     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Colditz GA and Frazier AL: Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev 4: 567-571, 1995.
2. Singh Y, Sayami P, Sayami G, Nakagawa H, Koreeda T, Hatano T and Tsubura A: Nepalese breast cancer in relation to reproductive factors: comparison between Nepalese and Japanese cases. Anticancer Res 22: 319-323, 2002.
3. Tamakoshi K, Yatsuya H, Wakai K, Suzuki S, Nishio K, Lin Y, Niwa Y, Kondo T, Yamamoto A, Tokudome S, Toyoshima H and Tamakoshi A; JACC Study Group: Impact of menstrual and reproductive factors on breast cancer risk in Japan: results of the JACC study. Cancer Sci 96: 57-62, 2005.
4. Brinton LA, Schairer C, Hoover RN and Fraumeni JF: Menstrual factors and risk of breast cancer. Cancer Invest 6: 245-254, 1998.
5. MacMahon B, Cole P and Brown J: Etiology of human breast cancer: a review. J Natl Cancer Inst 50: 21-42, 1973.
6. Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG and Yuasa S: Age at any birth and breast cancer risk. Int J Cancer 31: 701-704, 1983.
7. Nagata C, Hu YH and Shimizu H: Effects of menstrual and reproductive factors on the risk of breast cancer: meta-analysis of the case-control studies in Japan. Jpn J Cancer Res 86: 910-915, 1995.
8. Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, Burke KP, Titus-Ernstoff L, Trentham-Dietz A and MacMahon B: Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151: 715-722, 2000.
9. Lipworth L, Bailey LR and Trichopoulos D: History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature. J Natl Cancer Inst 92: 302-312, 2000.
10. Merrill RM, Fugal S, Novilla LB and Raphael MC: Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 96: 583-593, 2005.
11. Nelson NJ: Migrant studies aid the search for factors linked to breast cancer risk. J Natl Cancer Inst 98: 436-438, 2006.
12. Tsubura A, Uehara N, Kiyozuka Y and Shikata N: Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia 10: 87-100, 2005.
13. Nandi S, Guzman RC, Thordarson G and Rajkumar L: Estrogen can prevent breast cancer by mimicking the protective effect of pregnancy. In: Hormonal Carcinogenesis IV. Li JJ, Li SA and Llombart-Bosch A (eds.). New York, Springer, pp. 165-179, 2005.
14. Rajkumar L, Kittrell FS, Guzman RC, Brown PH, Nandi S and Medina D: Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models. Breast Cancer Res 9: R12, 2007.
15. Haslam SZ: Role of sex steroid hormones in normal mammary gland function. In: The Mammary Gland, Development, Regulation, and Function. Neville MC and Daniel CW (eds.). New York, Plenum Press, pp. 499-533, 1987.
16. Isaacs JT: Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46: 3958-3963, 1986.
17. Medina D and Smith GH: Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst 91: 967-969, 1999.
18. Medina D and Kittrell FS: p53 Function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 63: 6140-6143, 2003.
19. Grubbs CJ, Peckham JC and Cato KD: Mammary carcinogenesis in rats in relation to age at time of N-nitroso-N-methylurea administration. J Natl Cancer Inst 70: 209-212, 1983.
20. Thompson HJ, Adlakha H and Singh M: Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 13: 1535-1539, 1992.
21. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM and Green JE: The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19: 968-988, 2000.
22. Tsubura A, Yoshizawa K, Uehara N, Yuri T and Matsuoka Y: Multistep mouse mammary tumorigenesis through preneoplasia to neoplasia and acquisition of metastatic potential. Med Mol Morphol 40: 9-17, 2007.
23. Medina D: Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 12: 483-495, 2005.
24. Yang J, Yoshizawa K, Nandi S and Tsubura A: Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats. Carcinogenesis 20: 623-628, 1999.
25. Moon RC: Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int J Cancer 4: 312-317, 1969.
26. Moon RC: Influence of pregnancy and lactation on experimental mammary carcinogenesis. In: Banbury Report 8: Hormones and Breast Cancer. Pike MC, Siiteri P and Welsch CW (eds.). Cold Spring Harbor, Cold Spring Harbor Laboratory Press, pp. 353-364, 1981.
27. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW and Medina D: Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 19: 1573-1581, 1998.
28. Russo IH, Koszalka M and Russo J: Comparative study of the influence of pregnancy and hormonal treatment on mammary carcinogenesis. Br J Cancer 64: 481-484, 1991.
29. Grubbs CJ, Juliana MM and Whitaker LM: Short-term hormone treatment as a chemopreventive method against mammary cancer initiation in rats. Anticancer Res 8: 113-117, 1988.
30. Grubbs CJ, Farnell DR, Hill DL and McDonough KC: Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst 74: 927-931, 1985.
31. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X and Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96: 2520-2525, 1999.
32. Medina D, Peterson LE, Moraes R and Gay J: Short-term exposure to estrogen and progesterone induces partial protection against N-nitroso-N-methylurea-induced mammary tumorigenesis in Wistar-Furth rats. Cancer Lett 169: 1-6, 2001.
33. Sinha DK, Pazik JE and Dao TL: Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Br J Cancer 57: 390-394, 1988.
34. Huggins C, Moon RC and Morii S: Extinction of experimental mammary cancer. I. Estradiol-17beta and progesterone. Proc Natl Acad Sci USA 48: 379-386, 1962.
35. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F and Nandi S: Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci USA 98: 11755-11759, 2001.
36. Grubbs CJ, Peckham JC and McDonough KD: Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea-induced mammary cancer. Carcinogenesis 4: 495-497, 1983.
37. Tokunaga M, Land CE, Yamamoto T, Asano M, Tokuoka S, Ezaki H and Nishimori I: Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat Res 112: 243-272, 1987.
38. Grubbs CJ, Juliana MM, Hill DL and Whitaker LM: Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticancer Res 6: 1395-1400, 1986.
39. Grubbs CJ, Hill DL, McDonough KC and Peckham JC: N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J Natl Cancer Inst 71: 625-628, 1983.
40. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM and Chodosh LA: Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66: 6421-6431, 2006.
41. Sinha DK and Pazik JE: Tumorigenesis of mammary gland by 7,12-dimethylbenz(a)anthracene during pregnancy: relationship with DNA synthesis. Int J Cancer 27: 807-810, 1981.
42. Swanson SM and Christov K: Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency. Anticancer Res 23: 3207-3213, 2003.
43. Numan M: Maternal behavior. In: The Physiology of Reproduction. Knobil E and Neill JD (eds.). New York, Raven, pp. 221-302, 1994.
44. Yuri T, Tsukamoto R, Uehara N, Matsuoka Y and Tsubura A: Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rat. In Vivo 20: 829-836, 2006.
45. Tsukamoto R, Mikami T, Miki K, Uehara N, Yuri T, Matsuoka Y, Okazaki K and Tsubura A: N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats. Oncol Rep 18: 337-342, 2007.
46. Han BS, Fukamachi K, Takasuka N, Ohnishi T, Maeda M, Yamasaki T and Tsuda H: Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Carcinogenesis 23: 1209-1215, 2002.
47. Thordarson G, Semaan S, Low C, Ochoa D, Leong H, Rajkumar L, Guzman RC, Nandi S and Talamantes F: Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments. Breast Cancer Res Treat 87: 277-290, 2004.
48. Jerry DJ, Kittrell FS, Kuperwasser C, Laucirica R, Dickinson ES, Bonilla PJ, Butel JS and Medina D: A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development. Oncogene 19: 1052-1058, 2000.
49. Thordarson G, Van Horn K, Guzman RC, Nandi S and Talamantes F: Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones. Carcinogenesis 22: 1027-1033, 2001.
50. Abrams TJ, Guzman RC, Swanson SM, Thordarson G, Talamantes F and Nandi S: Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. Anticancer Res 18: 4115-4121, 1998.
51. Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S and Talamantes F: Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 16: 2847-2853, 1995.
52. Russo IH and Russo J: Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect 104: 938-967, 1996.
53. D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA and Chodosh LA: Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16: 2034-2051, 2002.
54. Uehara N, Unami A, Kiyozuka Y, Shikata N, Oishi Y and Tsubura A: Parous mammary glands exhibit distinct alterations in gene expression and proliferation responsiveness to carcinogenic stimuli in Lewis rats. Oncol Rep 15: 903-911, 2006.
55. Matsuoka Y, Fukamachi K, Uehara N, Tsuda H and Tsubura A: Induction of a novel histone deacetylase 1/c-Myc/Mnt/Max complex formation is implicated in parity-induced refractoriness to mammary carcinogenesis. Cancer Sci, in press.
56. Ginger MR, Gonzalez-Rimbau ME, Gay JP and Rosen JM: Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 15: 1993-2009, 2001.
57. Pierce DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ and Moses HL: Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc Natl Acad Sci USA 92: 4254-4258, 1995.
58. Verlinden I, Güngör N, Wouters K, Janssens J, Raus J and Michiels L: Parity-induced changes in global gene expression in the human mammary gland. Eur J Cancer Prev 14: 129-137, 2005.
59. Uehara N, Matsuoka Y and Tsubura A: Mesothelin promotes anchorage-independent growth and prevents anoikis via ERK signaling pathway in human breast cancer cells. Mol Cancer Res, in press.
60. Keyomarsi K and Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116, 1993.
61. Yan M, Schneider J, Gear R, Lu F, LaDow K, Warshawsky D and Heffelfinger SC: Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies. Pathobiology 71: 253-260, 2004.
62. Hadsell DL and Bonnette SG: IGF and insulin action in the mammary gland: lessons from transgenic and knockout models. J Mammary Gland Biol Neoplasia 5: 19-30, 2000.
63. Manni A, Badger B, Wei L, Zaenglein A, Grove R, Khin S, Heitjan D, Shimasaki S and Ling N: Hormonal regulation of insulin-like growth factor II and insulin-like growth factor binding protein expression by breast cancer cells in vivo: evidence for stromal epithelial interactions. Cancer Res 54: 2934-2942, 1994.
64. Papaconstantinou AD, Shanmugam I, Shan L, Schroeder IS, Qiu C, Yu M and Snyderwine EG: Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene. Int J Cancer 118: 17-24, 2006.
65. Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R and Bieche I: Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours. Br J Cancer 82: 142-150, 2000.
66. Satoh K, Ginsburg E and Vonderhaar BK: Msx-1 and Msx-2 in mammary gland development. J Mammary Gland Biol Neoplasia 9: 195-205, 2004.